EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenotypic and genotypic characterization of HMB-3, a metallo-beta-lactamase from Pseudomonas asiatica

Jacqueline Findlay iD, John Michael Shaw, Patrice Nordmann iD, Philip Hinchliffe, Evelin Bucheli Laffer, Yannick Born, Helena M B Seth-Smith, Adrian Egli iD, Niels Pfennigwerth iD, James Spencer, Laurent Poirel iD

Journal of Antimicrobial Chemotherapy · 05.05.2026 · 81 (6)

DOI: 10.1093/jac/dkag148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 06.05.2026. Verfasst von Jacqueline Findlay und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland. Hauptthemen laut MEDLINE: beta-Lactamases, Pseudomonas. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Office of Public Health, Swiss National Science Foundation, University of Zurich.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We describe the identification and characterization of the HMB-3 variant, produced by a P. asiatica isolate from a patient in Switzerland. Materials and methods A carbapenem-resistant P. asiatica isolate was sent to the Swiss National Reference Center for Emerging Antibiotic Resistance for investigation. Antibiotic susceptibility testing was performed according to CLSI guidelines. WGS was performed on Illumina and Oxford Nanopore platforms. The blaHMB alleles were cloned into the pCR-Blunt II-TOPO plasmid. Site-directed mutagenesis was performed on blaHMB-1 and blaHMB-3 inserted into the pTOPO plasmids. Purified HMB-1, HMB-3, NDM-1 and IMP-1 were used for steady state kinetic measurements of hydrolysis of selected beta-lactams. Results and discussion The isolate was obtained from a tracheostomy wound swab. Susceptibility testing showed that it was resistant to all beta-lactams, except aztreonam; however, no classical carbapenemase genes were identified by routine testing. WGS produced a complete chromosome of 6.1 Mb but no plasmids, and identified a gene encoding a novel MBL, namely HMB-3, differing from HMB-1 by 23 amino acid substitutions. HMB-3 was chromosomally encoded and located within a 25.6 kb genomic island. HMB-3 conferred resistance to most beta-lactam antibiotics, except piperacillin (MIC 4 mg/L), aztreonam (0.125 mg/L) and cefiderocol (2 mg/L). Site-directed mutagenesis of blaHMB-1 and blaHMB-3 revealed that a single amino acid change, E181H/H181E, in active site loop 10, could significantly alter the MIC of cefiderocol. HMB-3 demonstrated increased hydrolytic activity against cefiderocol compared with HMB-1 and NDM-1.

Conclusions

Here we described a novel MBL enzyme responsible for acquired resistance to carbapenems and reduced susceptibility to cefiderocol in Pseudomonas spp.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesPseudomonasHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsGenotypeCefiderocolSwitzerlandMutagenesis, Site-DirectedPseudomonas InfectionsPhenotypeWhole Genome Sequencingbeta-Lactams

Substanzen

beta-LactamasesAnti-Bacterial AgentsCefiderocolbeta-Lactams

Autor:innen und Institutionen

  • Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
  • School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
  • Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
  • Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau AG, Aarau, Switzerland.
  • Institute for Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland.
  • Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Jacqueline Findlay, Patrice Nordmann, Adrian Egli, Niels Pfennigwerth, Laurent Poirel

Förderung

  • Federal Office of Public Health
  • Swiss National Science Foundation
  • University of Zurich

Zitieren

APA

Findlay, J., Shaw, J. M., Nordmann, P., Hinchliffe, P., Laffer, E. B., Born, Y., Seth-Smith, H. M. B., Egli, A., Pfennigwerth, N., Spencer, J., & Poirel, L. (2026). Phenotypic and genotypic characterization of HMB-3, a metallo-beta-lactamase from Pseudomonas asiatica. Journal of Antimicrobial Chemotherapy, 81(6). https://doi.org/10.1093/jac/dkag148

Vancouver

Findlay J, Shaw JM, Nordmann P, Hinchliffe P, Laffer EB, Born Y, et al. Phenotypic and genotypic characterization of HMB-3, a metallo-beta-lactamase from Pseudomonas asiatica. Journal of Antimicrobial Chemotherapy. 2026;81(6). doi:10.1093/jac/dkag148

BibTeX
@article{Findlay2026,
  author = {Findlay, Jacqueline and Shaw, John Michael and Nordmann, Patrice and Hinchliffe, Philip and Laffer, Evelin Bucheli and Born, Yannick and Seth-Smith, Helena M B and Egli, Adrian and Pfennigwerth, Niels and Spencer, James and Poirel, Laurent},
  title = {Phenotypic and genotypic characterization of HMB-3, a metallo-beta-lactamase from Pseudomonas asiatica},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {6},
  doi = {10.1093/jac/dkag148}
}
Kostenlos starten →